Edge Therapeutics, Inc. Uncategorized Contracts & Agreements

13 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment to the Eighth Amended and Restated Certificate of Incorporation
Edge Therapeutics, Inc.
Biotechnology
2024
Executive Employment Agreement by and between Stephan F. Toutain and PDS Biotechnology Corporation, effective as of May 1, 2024
Edge Therapeutics, Inc.
Biotechnology
NJ
2024
PDS Biotechnology Corporation 2019 Inducement Plan, as amended
Edge Therapeutics, Inc.
Biotechnology
DE
2024
PDS Biotechnology Corporation 2019 Inducement Plan, as amended
Edge Therapeutics, Inc.
Biotechnology
DE
2022
Option Agreement with University of Georgia Research Foundation, Inc. effective as of October 25, 2021
Edge Therapeutics, Inc.
Biotechnology
GA
2022
PDS Biotechnology Corporation 2019 Inducement Plan, as amended
Edge Therapeutics, Inc.
Biotechnology
DE
2020
Description of Securities
Edge Therapeutics, Inc.
Biotechnology
2020
Offer Letter, dated February 1, 2019, by and between PDS Biotechnology Corporation and Lauren V. Wood, M.D
Edge Therapeutics, Inc.
Biotechnology
2019
PDS Biotechnology Corporation 2019 Inducement Plan
Edge Therapeutics, Inc.
Biotechnology
DE
2019
Letter Agreement, dated as of February 3, 2019, by and among Edge Therapeutics, Inc., PDS Biotechnology Corporation and Brian A. Leuthner
Edge Therapeutics, Inc.
Biotechnology
2019
Offer Letter, dated September 21, 2018, by and between PDS Biotechnology Corporation and Lauren Wood, MD
Edge Therapeutics, Inc.
Biotechnology
2018
EXECUTIVEEMPLOYMENT AGREEMENT
Edge Therapeutics, Inc.
Biotechnology
NJ
2015
AMENDMENT TO THEedge therapeutics, inc. 2010 EQUITYINCENTIVE Plan
Edge Therapeutics, Inc.
Biotechnology
2015